DONALD YEE to Neurotoxicity Syndromes
This is a "connection" page, showing publications DONALD YEE has written about Neurotoxicity Syndromes.
Connection Strength
0.048
-
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study. Blood Adv. 2023 10 24; 7(20):6055-6065.
Score: 0.048
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.